Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Income Statement, fiscal quarters · USD, as filed
| Line item | Feb 25 | Aug 25 | Nov 25 | Feb 26 | Aug 26 |
|---|---|---|---|---|---|
| Total revenue | $14.13B | $14.92B | $16.05B | $17.19B | $19.34B |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Gross margin |
Source: SEC filings. Information and analytics, not investment advice.
| — |
| — |
| — |
| — |
| — |
| Research & development | $2.42B | $2.49B | $2.56B | $2.60B | $2.40B |
| Selling, general & admin | — | — | — | — | — |
| Total operating expenses | — | — | — | — | — |
| Operating income | $4.35B | $4.27B | $4.73B | $5.46B | $6.72B |
| Operating margin | 3080.0% | 2870.0% | 2950.0% | 3180.0% | 3480.0% |
| Interest expense | $892.00M | $923.00M | $1.05B | $1.18B | $1.42B |
| Pretax income | — | — | — | — | — |
| Tax provision | $512.00M | $500.00M | $207.00M | $695.00M | $847.00M |
| Net income | $2.93B | $2.92B | $6.13B | $3.72B | $4.76B |
| Net margin | 2080.0% | 1960.0% | 3820.0% | 2160.0% | 2460.0% |
| EBITDA | — | $6.10B | — | — | $10.23B |
| Basic EPS | 1.05 | 1.04 | 2.14 | 1.29 | 1.58 |
| Diluted EPS | 1.02 | 1.01 | 2.1 | 1.27 | 1.56 |